Skip to main content

Table 1 Baseline characteristics of the study cohort

From: Adenosine stress CMR T1-mapping detects early microvascular dysfunction in patients with type 2 diabetes mellitus without obstructive coronary artery disease

Variable

Healthy Controls

N = 16

T2DM

N = 31

P value

Age, y

51 ± 9

55 ± 9

0.162

BMI, kg/m2

25.8 ± 4.2

28.7 ± 5.6

0.083

Male, %

53

58

0.739

Diabetes duration, y

…

7[IQR:1–8]

 

Systolic blood pressure, mmHg

121 ± 13

125 ± 11

0.366

Diastolic blood pressure, mmHg

71 ± 9

77 ± 8

0.048

Resting heart rate, bpm

58 ± 10

69 ± 8

<0.001

Plasma fasting glucose

4.8 ± 0.5

9.1 ± 3.2

<0.001

Plasma triglycerides, mmol/L

1.25 ± 0.68

1.47 ± 0.71

0.391

Total cholesterol, mmol/L

3.58 ± 0.93

1.99 ± 0.63

<0.001

HDL, mmol/L

1.32 ± 0.37

1.22 ± 0.36

0.442

LDL, mmol/L

2.86 ± 0.56

1.99 ± 0.63

<0.001

Hematocrit, %

41 ± 4

42 ± 3

0.501

Medications, n (%)

 Metformin

–

30 (97)

 

 Sulphonylurea

–

21 (68)

 

 Aspirin

–

11 (35)

 

 Statin

–

24 (77)

 

 ACE-I

–

21 (68)

 
  1. Values are mean ± standard deviations or percentages. T2DM indicates type 2 diabetes mellitus; BMI, body mass index; y, years; bpm, beats per minute; HDL, high density lipoprotein; LDL, low density lipoprotein; ACE-I angiotensin-converting enzyme inhibitors